Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $7.6 million.

  • Collegium Pharmaceutical's Accounts Payables rose 14338.0% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 million, marking a year-over-year increase of 14338.0%. This contributed to the annual value of $3.9 million for FY2024, which is 5474.0% down from last year.
  • Collegium Pharmaceutical's Accounts Payables amounted to $7.6 million in Q3 2025, which was up 14338.0% from $10.9 million recorded in Q2 2025.
  • Collegium Pharmaceutical's Accounts Payables' 5-year high stood at $17.9 million during Q1 2025, with a 5-year trough of $2.4 million in Q2 2024.
  • Moreover, its 5-year median value for Accounts Payables was $6.0 million (2024), whereas its average is $6.3 million.
  • In the last 5 years, Collegium Pharmaceutical's Accounts Payables tumbled by 6348.27% in 2023 and then surged by 35149.25% in 2025.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's Accounts Payables stood at $4.2 million in 2021, then dropped by 16.59% to $3.5 million in 2022, then soared by 148.77% to $8.7 million in 2023, then tumbled by 54.74% to $3.9 million in 2024, then skyrocketed by 94.38% to $7.6 million in 2025.
  • Its Accounts Payables was $7.6 million in Q3 2025, compared to $10.9 million in Q2 2025 and $17.9 million in Q1 2025.